MedPlus Health Services Limited (NSE:MEDPLUS)
India · Delayed Price · Currency is INR 801.10
-7.85 (-0.97%)
Jul 17, 2026, 3:30 PM IST
MedPlus Health Services Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, MedPlus Health Services stock has a consensus rating of "Strong Buy" and an average price target of ₹1,169. The average 1-year stock price forecast is 45.89% higher than the current stock price, while the lowest is ₹1,100 (+37.31%) and the highest is ₹1,271 (+58.66%).
Price Target: ₹1,169 (+45.89%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Feb 11, 2026.
Analyst Ratings
The average analyst rating for MedPlus Health Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Keynote Capitals No rating | Keynote Capitals | Buy Maintains ₹1,155 | Buy | Maintains | ₹1,155 | +44.18% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
78.65B
from 68.92B
Increased by 14.10%
Revenue Next Year
91.17B
from 78.65B
Increased by 15.93%
EPS This Year
21.67
from 18.29
Increased by 18.48%
EPS Next Year
25.54
from 21.67
Increased by 17.88%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.